Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
- Finding Immune Nascent Type 1 DiabetesNot Yet Recruiting
Sponsor: Indiana University
Healthy Adult · Type 1 Diabetes (T1D)
United States
Sponsor: Sanofi
Solid Tumor
United States, Chile, Israel, Japan, Netherlands +1 more
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisRecruiting
Sponsor: Sanofi
Colitis Ulcerative
United States, Argentina, Australia, Austria, Belgium +17 more
- Pompe Disease Registry ProtocolRecruiting
Sponsor: Genzyme, a Sanofi Company
Glycogen Storage Disease Type II · Pompe Disease
United States, Argentina, Australia, Belgium, Brazil +39 more
- Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related DisordersActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Langerhans Cell Histiocytosis
United States, Canada
Sponsor: Ottawa Heart Institute Research Corporation
Diabetes Mellitus, Type 2 · Coronary Disease
Canada
Sponsor: Sanofi Pasteur, a Sanofi Company
Respiratory Syncytial Virus Immunization
Germany
Sponsor: Sanofi
Immune Thrombocytopenia
United States, Austria, Czechia, France, Germany +4 more
Sponsor: Sanofi
Crohn's Disease
United States, Canada, Georgia, Japan, Moldova +2 more
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous PemphigoidCompleted
Sponsor: Regeneron Pharmaceuticals
Bullous Pemphigoid
United States, Australia, France, Germany, Israel +4 more
- Safety and Efficacy of Avalglucosidase Alfa in Patients With Non-classic Pompe Disease Aged ≥ 5 YearsActive Not Recruiting
Sponsor: Iris Plug
Glycogen Storage Disease Type II Late Onset · Pompe Disease (Late-onset) · Pompe Disease Late-Onset · Pompe's Disease Juvenile Onset
Netherlands
Sponsor: Sanofi
Plasma Cell Myeloma Refractory
United States, Australia, France, Germany, Greece +5 more
Sponsor: Sanofi
Gaucher's Disease Type I · Gaucher's Disease Type III
Argentina, Canada, France, Italy, Japan +5 more
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Australia, Brazil, Canada +9 more
Sponsor: Sanofi
Crohn's Disease
United States, Argentina, Australia, Brazil, Bulgaria +19 more
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Brazil, Canada, China +14 more
Sponsor: Thomas Martin, MD
Multiple Myeloma
United States, Canada
Sponsor: Sanofi
Rheumatoid Arthritis · Psoriatic Arthritis
France
- Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid FailureNot Yet Recruiting
Sponsor: Dennis Kim
cGVHD
Canada
- A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 YearsActive Not Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Epstein-Barr Virus (EBV) · Healthy Volunteers
Australia
Sponsor: Dana-Farber Cancer Institute
Bronchiolitis Obliterans Syndrome · Bronchiolitis Obliterans · Lung Diseases · Chronic Graft Versus Host Disease
United States
Sponsor: Cytokinetics
Obstructive Hypertrophic Cardiomyopathy (oHCM)
United States, Brazil, Canada, China, Denmark +8 more
- Isa-Pom-Dex in Elderly/Frail Subjects With RRMMActive Not Recruiting
Sponsor: UNC Lineberger Comprehensive Cancer Center
Multiple Myeloma · Relapse · Refractory · Aging
United States
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza · Healthy Volunteers
United States, Australia
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma
United States